Additionally, tumor resident CD103+ NK cells express more inhibitory receptors, such as TIGIT and TIM-3, as compared with recruited NK cells, indicating the undermined NK-mediated immunosurveillance in TME [72]. The gene discussed is HAVCR2; the disease is neoplasm.